{"name":"Eisai Co., Ltd.","slug":"eisai-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":25,"colorKey":"oncology","drugs":[{"name":"E2020","genericName":"E2020","slug":"e2020","indication":"Other","status":"marketed"},{"name":"E0671","genericName":"E0671","slug":"e0671","indication":"Other","status":"marketed"},{"name":"E2022- New Formula Tape","genericName":"E2022- New Formula Tape","slug":"e2022-new-formula-tape","indication":"Other","status":"phase_1"},{"name":"E2027","genericName":"E2027","slug":"e2027","indication":"Other","status":"phase_2"},{"name":"Eszopiclone 1 mg- Elderly","genericName":"Eszopiclone 1 mg- Elderly","slug":"eszopiclone-1-mg-elderly","indication":"Insomnia in elderly patients (sleep onset and sleep maintenance)","status":"phase_3"},{"name":"Eszopiclone 2 mg- Elderly","genericName":"Eszopiclone 2 mg- Elderly","slug":"eszopiclone-2-mg-elderly","indication":"Other","status":"phase_3"},{"name":"Selbex","genericName":"Selbex","slug":"selbex","indication":"Other","status":"marketed"},{"name":"E0302 SR1","genericName":"E0302 SR1","slug":"e0302-sr1","indication":"Other","status":"phase_1"},{"name":"E0302 SR2","genericName":"E0302 SR2","slug":"e0302-sr2","indication":"Other","status":"phase_1"},{"name":"E0302 SR3","genericName":"E0302 SR3","slug":"e0302-sr3","indication":"Other","status":"phase_1"},{"name":"E2022","genericName":"E2022","slug":"e2022","indication":"Other","status":"phase_1"},{"name":"E2022 Tape Formulation","genericName":"E2022 Tape Formulation","slug":"e2022-tape-formulation","indication":"Other","status":"phase_1"},{"name":"E2022- Current Formula Tape","genericName":"E2022- Current Formula Tape","slug":"e2022-current-formula-tape","indication":"Other","status":"phase_1"},{"name":"E2307","genericName":"E2307","slug":"e2307","indication":"Other","status":"phase_1"},{"name":"E3710","genericName":"E3710","slug":"e3710","indication":"Other","status":"phase_1"},{"name":"E6742","genericName":"E6742","slug":"e6742","indication":"Other","status":"phase_1"},{"name":"Equfina","genericName":"Equfina","slug":"equfina","indication":"Other","status":"phase_2"},{"name":"Eszopiclone 2 mg- Non-elderly","genericName":"Eszopiclone 2 mg- Non-elderly","slug":"eszopiclone-2-mg-non-elderly","indication":"Insomnia (sleep initiation and maintenance) in non-elderly adults","status":"phase_3"},{"name":"Eszopiclone 3 mg- Non-elderly","genericName":"Eszopiclone 3 mg- Non-elderly","slug":"eszopiclone-3-mg-non-elderly","indication":"Insomnia (sleep initiation and maintenance) in non-elderly adults","status":"phase_3"},{"name":"Group A: E5501 5mg, then 20mg, then 40 mg, then 5mg","genericName":"Group A: E5501 5mg, then 20mg, then 40 mg, then 5mg","slug":"group-a-e5501-5mg-then-20mg-then-40-mg-then-5mg","indication":"Other","status":"phase_1"},{"name":"Mecobalamin IV Injection","genericName":"Mecobalamin IV Injection","slug":"mecobalamin-iv-injection","indication":"Other","status":"marketed"},{"name":"Mecobalamin IV or IM injection","genericName":"Mecobalamin IV or IM injection","slug":"mecobalamin-iv-or-im-injection","indication":"Other","status":"marketed"},{"name":"Tasurgratinib","genericName":"Tasurgratinib","slug":"tasurgratinib","indication":"Other","status":"phase_1"},{"name":"lysozyme 90 mg","genericName":"lysozyme 90 mg","slug":"lysozyme-90-mg","indication":"Other","status":"marketed"},{"name":"pembrolizumab (200 mg)","genericName":"pembrolizumab (200 mg)","slug":"pembrolizumab-200-mg","indication":"Other","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"cardiovascular","drugs":[{"name":"Mecobalamin IM injection","genericName":"Mecobalamin IM injection","slug":"mecobalamin-im-injection","indication":"Vitamin B12 deficiency with neurological manifestations","status":"marketed"},{"name":"E3810","genericName":"E3810","slug":"e3810","indication":"Schizophrenia","status":"phase_3"},{"name":"BOTULINUM TOXIN TYPE B","genericName":"BOTULINUM TOXIN TYPE B","slug":"botulinum-toxin-type-b","indication":"Cervical dystonia","status":"marketed"},{"name":"E2020-Donepezil hydrochloride","genericName":"E2020-Donepezil hydrochloride","slug":"e2020-donepezil-hydrochloride","indication":"Moderate to severe dementia of the Alzheimer's type","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"Eperisone hydrochloride and Diclofenac sodium","genericName":"Eperisone hydrochloride and Diclofenac sodium","slug":"eperisone-hydrochloride-and-diclofenac-sodium","indication":"Acute musculoskeletal pain and muscle spasticity","status":"phase_3"},{"name":"Eperisone hydrochloride","genericName":"Eperisone hydrochloride","slug":"eperisone-hydrochloride","indication":"Muscle tension and spasticity associated with musculoskeletal disorders","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"E7090","genericName":"E7090","slug":"e7090","indication":"Type 2 diabetes","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"E7389 (Eribulin Mesylate)","genericName":"E7389 (Eribulin Mesylate)","slug":"e7389-eribulin-mesylate","indication":"Metastatic breast cancer","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Lysozyme hydrochloride","genericName":"Lysozyme hydrochloride","slug":"lysozyme-hydrochloride","indication":"Bacterial infections (topical/local use)","status":"marketed"}]}],"pipeline":[{"name":"E2020","genericName":"E2020","slug":"e2020","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E7090","genericName":"E7090","slug":"e7090","phase":"phase_2","mechanism":"E7090 is a selective and potent inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Mecobalamin IM injection","genericName":"Mecobalamin IM injection","slug":"mecobalamin-im-injection","phase":"marketed","mechanism":"Mecobalamin is an active form of vitamin B12 that replenishes cellular cobalamin stores and restores normal methylation and energy metabolism.","indications":["Vitamin B12 deficiency with neurological manifestations","Peripheral neuropathy associated with B12 deficiency","Subacute combined degeneration","Pernicious anemia with neurological complications"],"catalyst":""},{"name":"E0671","genericName":"E0671","slug":"e0671","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E2022- New Formula Tape","genericName":"E2022- New Formula Tape","slug":"e2022-new-formula-tape","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E2027","genericName":"E2027","slug":"e2027","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E3810","genericName":"E3810","slug":"e3810","phase":"phase_3","mechanism":"E3810 is a small-molecule inhibitor of phosphodiesterase 10A (PDE10A) that increases intracellular cyclic nucleotide signaling in the brain.","indications":["Schizophrenia","Parkinson's disease psychosis"],"catalyst":""},{"name":"Eperisone hydrochloride and Diclofenac sodium","genericName":"Eperisone hydrochloride and Diclofenac sodium","slug":"eperisone-hydrochloride-and-diclofenac-sodium","phase":"phase_3","mechanism":"This combination product uses eperisone as a muscle relaxant and diclofenac as an NSAID to reduce muscle tension and inflammation-related pain.","indications":["Acute musculoskeletal pain and muscle spasticity","Pain associated with muscle tension and inflammation"],"catalyst":""},{"name":"Eszopiclone 1 mg- Elderly","genericName":"Eszopiclone 1 mg- Elderly","slug":"eszopiclone-1-mg-elderly","phase":"phase_3","mechanism":"Eszopiclone is a nonbenzodiazepine hypnotic that binds to GABA-A receptors in the brain to promote sleep onset and maintenance.","indications":["Insomnia in elderly patients (sleep onset and sleep maintenance)"],"catalyst":""},{"name":"Eszopiclone 2 mg- Elderly","genericName":"Eszopiclone 2 mg- Elderly","slug":"eszopiclone-2-mg-elderly","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Selbex","genericName":"Selbex","slug":"selbex","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BOTULINUM TOXIN TYPE B","genericName":"BOTULINUM TOXIN TYPE B","slug":"botulinum-toxin-type-b","phase":"marketed","mechanism":"Botulinum toxin type B blocks acetylcholine release at the neuromuscular junction by cleaving SNARE proteins, causing temporary muscle paralysis.","indications":["Cervical dystonia","Blepharospasm","Strabismus","Hyperhidrosis","Migraine prophylaxis"],"catalyst":""},{"name":"E0302 SR1","genericName":"E0302 SR1","slug":"e0302-sr1","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E0302 SR2","genericName":"E0302 SR2","slug":"e0302-sr2","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E0302 SR3","genericName":"E0302 SR3","slug":"e0302-sr3","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E2020-Donepezil hydrochloride","genericName":"E2020-Donepezil hydrochloride","slug":"e2020-donepezil-hydrochloride","phase":"phase_2","mechanism":"Donepezil hydrochloride is a cholinesterase inhibitor that works by increasing the concentration of acetylcholine in the brain, which helps to improve cognitive function in patients with Alzheimer's disease.","indications":["Moderate to severe dementia of the Alzheimer's type"],"catalyst":""},{"name":"E2022","genericName":"E2022","slug":"e2022","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E2022 Tape Formulation","genericName":"E2022 Tape Formulation","slug":"e2022-tape-formulation","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E2022- Current Formula Tape","genericName":"E2022- Current Formula Tape","slug":"e2022-current-formula-tape","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E2307","genericName":"E2307","slug":"e2307","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E3710","genericName":"E3710","slug":"e3710","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E6742","genericName":"E6742","slug":"e6742","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"E7389 (Eribulin Mesylate)","genericName":"E7389 (Eribulin Mesylate)","slug":"e7389-eribulin-mesylate","phase":"phase_3","mechanism":"Eribulin is a microtubule dynamics inhibitor that suppresses microtubule growth and induces apoptosis in cancer cells.","indications":["Metastatic breast cancer","Liposarcoma","Other solid tumors (in clinical development)"],"catalyst":""},{"name":"Eperisone hydrochloride","genericName":"Eperisone hydrochloride","slug":"eperisone-hydrochloride","phase":"phase_3","mechanism":"Eperisone hydrochloride is a muscle relaxant that reduces muscle tension by inhibiting monoamine oxidase and enhancing noradrenergic and serotonergic neurotransmission in the central nervous system.","indications":["Muscle tension and spasticity associated with musculoskeletal disorders","Cervical spondylosis with muscle stiffness","Lower back pain with muscle tension"],"catalyst":""},{"name":"Equfina","genericName":"Equfina","slug":"equfina","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Eszopiclone 2 mg- Non-elderly","genericName":"Eszopiclone 2 mg- Non-elderly","slug":"eszopiclone-2-mg-non-elderly","phase":"phase_3","mechanism":"Eszopiclone is a nonbenzodiazepine hypnotic that binds to GABA-A receptors in the brain to enhance inhibitory neurotransmission and promote sleep.","indications":["Insomnia (sleep initiation and maintenance) in non-elderly adults"],"catalyst":""},{"name":"Eszopiclone 3 mg- Non-elderly","genericName":"Eszopiclone 3 mg- Non-elderly","slug":"eszopiclone-3-mg-non-elderly","phase":"phase_3","mechanism":"Eszopiclone is a nonbenzodiazepine hypnotic that binds to GABA-A receptors in the brain to enhance inhibitory neurotransmission and promote sleep.","indications":["Insomnia (sleep initiation and maintenance) in non-elderly adults"],"catalyst":""},{"name":"Group A: E5501 5mg, then 20mg, then 40 mg, then 5mg","genericName":"Group A: E5501 5mg, then 20mg, then 40 mg, then 5mg","slug":"group-a-e5501-5mg-then-20mg-then-40-mg-then-5mg","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Lysozyme hydrochloride","genericName":"Lysozyme hydrochloride","slug":"lysozyme-hydrochloride","phase":"marketed","mechanism":"Lysozyme hydrochloride is an antimicrobial enzyme that breaks down bacterial cell walls by cleaving peptidoglycan, thereby killing bacteria and reducing infection.","indications":["Bacterial infections (topical/local use)","Dry eye syndrome (as a component of tear substitutes)"],"catalyst":""},{"name":"Mecobalamin IV Injection","genericName":"Mecobalamin IV Injection","slug":"mecobalamin-iv-injection","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Mecobalamin IV or IM injection","genericName":"Mecobalamin IV or IM injection","slug":"mecobalamin-iv-or-im-injection","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tasurgratinib","genericName":"Tasurgratinib","slug":"tasurgratinib","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"lysozyme 90 mg","genericName":"lysozyme 90 mg","slug":"lysozyme-90-mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"pembrolizumab (200 mg)","genericName":"pembrolizumab (200 mg)","slug":"pembrolizumab-200-mg","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPVWhhaFFDNDNVbWRhNGVTMG54TFRRTmRyTFhyM1dUZ1pIbUlUdVNMZFlXcE03RWhUc0pVUlBjdWpqcGJUSzNaV0NsOFFtd3NTNUpfdWVOcDNZYzcyajRDSlNqWGVMZU9iVXNsQTRJRnphSG1CNFZSbU40aEFEWXJyZTUyRml0ZWNveUJIU1dCRVk0R2xiXzF0azdIZFI3ZmNsLV9uNFdCZkM5VEJieTVnVmxNNjZCU3FWelBTTzNn?oc=5","date":"2026-04-02","type":"pipeline","source":"AD HOC NEWS","summary":"Eisai Co Ltd Stock: Japanese Pharma Leader Focused on Neurology with Global Reach for North American - AD HOC NEWS","headline":"Eisai Co Ltd Stock: Japanese Pharma Leader Focused on Neurology with Global Reach for North American","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNWXRwdGNuZGZzbE5aRWhiVm15V2JheDV0QnUxN2VjUHVoY0p4UWdyNy1HT3RFUHVjQ3ZuUkEza2hJckNBa2owZjFyM2NFaU9nTkxJanlJUjJmTktDNldTeHNmUkM4X19wMFhGeFg1WEFOLU1KdG92Y2xVN1dSNWtqMnZEbVljLS1uelNqR1Q0Q3JPeFRsaDlETzlJanZpczc1NzVHaV9uUFZ3cnJSalRIaUVDXzQ3d3hoaXJQc2ttSQ?oc=5","date":"2026-03-16","type":"pipeline","source":"AD HOC NEWS","summary":"Eisai Co Ltd Stock (ISIN: JP3160400002) Holds Steady at €26.34 as Pharma Valuations Stabilize - AD HOC NEWS","headline":"Eisai Co Ltd Stock (ISIN: JP3160400002) Holds Steady at €26.34 as Pharma Valuations Stabilize","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPNkRyZkN4aDNaLTBUb2lSa0ZQdUJlUzlkcGNEMGpEQWF6ZHBmbTh3V3RyWU55eTk3WTFrOUd0bU1Wa1VjakdYQ0pPenQ0ZFVxY21UcFktTkdneF9BNlFoMGlyRU5aUHNvOWktZ09mSDNQSGVKVS1UNU9kVzI1bXR0QW5RM3JpSzVMc1I5eUFYV1VqMlNDRlNhaW41UUdxTnVLMngxYTVTWVV2RlcxX3VHbzBiQ0NCdnRhWDV3b0pVdC12bHNobVdZLUZZQ0tWN3FYcWpOamJwZw?oc=5","date":"2026-02-17","type":"pipeline","source":"BioPharma APAC","summary":"Eisai Co Ltd Receives Orphan Drug Designation In Japan For Novel Orexin 2 Receptor Agonist E2086 - BioPharma APAC","headline":"Eisai Co Ltd Receives Orphan Drug Designation In Japan For Novel Orexin 2 Receptor Agonist E2086","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNTjMxVFhfOU56V1pzOFFxWWd2eWIzMTNTS1BUd1A3NFJjVGpqR0dFX2JEdTJpX1BwcnNicXdlLWVPM1BRbmVRcU5TSzN5Uy1QNDRqbUw0QXRGXzIyMU9qSmFjNU5CNzB4ZzNhRHdFb3RkS2RmRDlpanM3VzFsUDRQeW52NVJwWlVQcWhELXV1OV9hdjNsX1VqbVEydmNwVjJ5N0w4MTNpNS1pUlZvNVpEU0V5blZsbkZraFFpWVpYQURXZHFXNnZ4dGU3QVZuS2dqRWc?oc=5","date":"2026-02-06","type":"deal","source":"Reuters","summary":"Eisai strikes Japan licensing deal with Shanghai Henlius Biotech - Reuters","headline":"Eisai strikes Japan licensing deal with Shanghai Henlius Biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxNRG12S3NpMEktUmxVUjBCdlhJRFljTjNZbUhFVkZWd05OcVVvTFFNTVdUSDNzTW1BMHQ3U3VjejB1bGlSYTAzQ3k4OFZSa1Q3dHBMbDB1LXRQZHh3Tjl1YVB6LV9hakhBM1BudWRKT3NIOUYtY0t2TUJoWFl4ZHgzUkdwb0g4U2xncEtJOEQ5OExrZVNWT051YTF0QTQwU3lFSFczNS1kZDhwZjZZdnUyRHR1YTU0UVBWZHRDbVJxcDRGU3N4SUxNNGs5Yk90V3JGbEhrRzc3dENOeVlDNC1NVEJWS3hOckZZUkYtaXRPX1RwdWRiTmZib21QcVpJYWM?oc=5","date":"2026-01-13","type":"deal","source":"Citeline News & Insights","summary":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","headline":"Asia Deal Watch: Eisai Obtains Rights To Nuvation’s Ibtrozi Outside US, Japan, China - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxNSXBvSjJ0ckFhWDFIZ2k2dENaVkowZGQ3enVNNHpITHNoamVKREEzSXgzSmRJSUEzOXA1S01sSmttMHlUUjNCczJ4TklrSHVoYmlwMm92QnRtT2drNHVBVEM2Z0pxbExKdFdJSnkwSV9IM1RmNm1KcU1sQkVveERDcUpsdTdiTFNGbWJub0FaQ2NiU1ZaNnNQR0ZXZzhNQUYzbjFuZFBLNG5vSko4eUd1TTNfSkxnQWkyZ1hIU2dnMDllQlZWalNMWHNvZ2RHOG9vSFhST09Wc3gwSEkyZjdROVRBcS1GTUk0VHp6U1U2Vlo5YU5qc2xNT0F2LS1HVC1pVTR3NFZsNE13eVJUUThVRGtjMXVTOWs?oc=5","date":"2026-01-07","type":"trial","source":"BioSpace","summary":"EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan - BioSpace","headline":"EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxONEllRTZqTU5qalAtc3U2NUVmWWJDX284NXBOTEhWdTN2QzRYa2h5OUtzdTdrc0R4YlpVY3JBOTdEMklYQXRZb3VLM25OdU82TE5OdFh5TEFhOTljYmZHcnVkU1dTQzVxZDhxdmE1TW1YN1RFRGM5dGpMbXlzc240V0twcEZBeUFOdXFuaWRJaF8xRFVvUzRHV2tnMERLYlhQb1dLUFAxU1FNSWpqOVNSa2VZZk5kV2IwYUtoQi1DOF9iQlhkS0pWTm1KbFU5QVhtakE?oc=5","date":"2025-08-29","type":"regulatory","source":"Reuters","summary":"US FDA approves injectable version of Eisai-Biogen's Alzheimer's drug - Reuters","headline":"US FDA approves injectable version of Eisai-Biogen's Alzheimer's drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOVV9GVHM0Nm14U2REMkdtWExBeXR6T09zUlFVb1Y2aVVCMGJBaGRKLU5uaUh2ZVNKdDJwd2lMTW00a2s5dU5jQnJvRG50T1RMdnhRMlpVcUxlY1JMX2tlUUo0dnVIb0dvd01RVGxNaWV0U3llaTlVbXlKZi14QWV3T0N3WlBlaGo0cTRLZ01FLURRTWlkYmlldnNKeVY5M0ttSDVPY3pXTmR5VlZDU0E5X0dObVZVSTh5UGZwRkZNMUU5QUtwMU9xdS0weHo3RmNSMUZUbG9YRkU5Umc0dWRrVndENA?oc=5","date":"2025-08-29","type":"regulatory","source":"Reuters","summary":"FDA recommends more monitoring of Alzheimer's patients on Eisai-Biogen's drug Leqembi - Reuters","headline":"FDA recommends more monitoring of Alzheimer's patients on Eisai-Biogen's drug Leqembi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9zMVhvSXZ1ZzlVVnI5aFdVT1Q4R29udjl0OW5NUWYtUHltTU5EcjJaQ1d3STE4czZDZlo2VEFIdWRsbkNoV3VSZndWdkhHdkVHQ0Y0aGc1ejNUT2MxMjc2eXRLSVZ2aTZvdFlKNmttWnpkM20xbEE?oc=5","date":"2023-06-07","type":"pipeline","source":"The Record from Recorded Future News","summary":"Japanese pharma giant Eisai working with law enforcement to resolve ransomware attack - The Record from Recorded Future News","headline":"Japanese pharma giant Eisai working with law enforcement to resolve ransomware attack","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxPZWY0aXZMb0ZRUFVfN1o3VkZHd3UxeG42RUdCbC1EZVhiSTNHbTQ3VXNwZGp4Si1nQ0R4UWswblNLVlAxbFB5Qkh3RVRPVFJrLU1EZUYtelE2M1VmNzhOWXlWUFBaYVVwVGV6UG5MemRkVHFqZ2lYbzZkZnJUNmJjbzZwakg3NzhReU95Vzd1OVpQS1RuZktKNDB1R2lmWjdUUHlRcmZOWkFCeHdpd2FNU1E4TUNNTU9RTnpLQW5uSk9kbUxzaldydzZQbU02dGN4bW0zRVJ4VHF1clZGdS1ub093ZUZJZVdiYWduQmF3SVJaYnBhQTZpMTM1a3RhcGMtdzNxeDJjM2pVTU1ELWtWS0ZPakFGTnF6?oc=5","date":"2022-12-21","type":"pipeline","source":"PR Newswire","summary":"Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceutical Packaging - PR Newswire","headline":"Astellas, Eisai, Daiichi Sankyo and Takeda Agree to Collaborate to Reduce Environmental Burden in the Field of Pharmaceu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE9NTjRPcGoxcTZGSnFXVm9fN3dnU19vTUxWdkdzRVYwdjdhcVk2SnJZcExpTk1iV1U5S3JFSUtneGFadHlCNnJGUWdlTjN3ZmpYMGxBcjB6MjAxbzNX?oc=5","date":"2018-11-29","type":"pipeline","source":"Eisai","summary":"MOVICOL® Launched in Japan - Eisai","headline":"MOVICOL® Launched in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE96R0NfVkE2aXhYRl9SRXREU2M3YU9OVVlYNndNM0xGaXZnMWtROHdUcFB3WU9wdUlBZnBzWjhkWmIzRl94eWFvR1RhbElvYkVCTU9ZMWxVYUJDVTNvOXUtZg?oc=5","date":"2013-07-11","type":"deal","source":"Eisai","summary":"Eisai co-establishes “Global Health Innovative Technology Fund,” Japan's first public–private partnership to eliminate infectious disease in developing countries | Patients and People - Eisai","headline":"Eisai co-establishes “Global Health Innovative Technology Fund,” Japan's first public–private partnership to eliminate i","sentiment":"neutral"}],"patents":[],"drugCount":34,"phaseCounts":{"marketed":9,"phase_2":4,"phase_1":12,"phase_3":9},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}